All 12 studies offered WHO grade data, 2 studies analyzed the correlation between CD34 and age and gender, 1 also studied the factor of tumor size, and the other studied the correlation between CD34 and tumor location, whether there was relapse or not, and it was not dependent on survival time. This evidence concerns the gene CD34 and neoplasm.